Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells

Telmo A Mejía-García1, Camila C Portugal, Thaísa G Encarnação

  • 1Program of Neurosciences and Department of Neurobiology, Institute of Biology, Fluminense Federal University, Niterói, RJ, Brazil.

Cellular Signalling
|August 21, 2013
PubMed

Insights

Nitric oxide (NO) activates AKT phosphorylation and nuclear translocation in retinal neurons, promoting cell survival. This pathway involves cyclic GMP/protein kinase G and phosphoinositide 3-kinase, crucial for central nervous system development.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Signaling

Background:

  • Nitric oxide (NO) is known to inhibit retinal neuron apoptosis via cyclic GMP/protein kinase G (PKG) and kinase pathways like PI3k/AKT.
  • AKT and NO are crucial for central nervous system (CNS) development and plasticity, exhibiting survival-promoting properties.

Purpose of the Study:

  • To investigate the effects of exogenous NO (S-nitroso-N-acetylpenicillamin, SNAP) and endogenous NO (l-arginine) on AKT phosphorylation in cultured chick retinal neurons.
  • To elucidate the signaling pathways involved in NO-mediated AKT activation and its role in neuronal survival.

Main Methods:

  • Treatment of cultured chick retinal neurons with NO donors (SNAP) or precursors (l-arginine).
  • Assessment of AKT phosphorylation at serine-473 and threonine-308 using specific inhibitors (ODQ, LY83583, KT5823, LY294002, wortmannin, KU0063794) and activators (YC-1, 8-Bromo cyclic GMP, zaprinast).
  • Evaluation of NMDA receptor involvement and NO synthase inhibition. Analysis of AKT translocation to the nucleus and protection against hydrogen peroxide-induced cell death.

Main Results:

  • SNAP and l-arginine significantly enhanced AKT phosphorylation in a time- and concentration-dependent manner.
  • The observed effects were mediated by soluble guanylyl cyclase, PKG, phosphoinositide 3-kinase, and the mTORC2 complex.
  • Glutamate and NMDA promoted AKT phosphorylation, dependent on NO production. SNAP and l-arginine induced AKT nuclear translocation and protected retinal cells from oxidative stress.

Conclusions:

  • Nitric oxide, from both endogenous and exogenous sources, activates AKT signaling in retinal neurons.
  • NO-induced AKT activation involves the PKG and PI3k/mTORC2 pathways and leads to nuclear translocation of AKT.
  • This NO-mediated AKT activation pathway plays a significant role in neuronal survival, particularly during CNS development.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...